• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018. “Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news

The ‘invented persona’ behind a key pandemic database
When Jeremy Kamil started to sequence samples of the rapidly spreading pandemic coronavirus in the spring of 2020, it was clear where he should deposit the genetic data: in GISAID , a long-running database for influenza genomes that had established itself as the go-to repository for SARS-CoV-2 as well. Kamil, a virologist at Louisiana State University’s (LSU’s) Health Sciences Center Shreveport, says he quickly struck up a friendly relationship with a Steven Meyers, who used a gisaid.org email address. The two often exchanged emails and talked on the phone, sometimes for hours, about the pandemic and data sh...
Source: ScienceNOW - April 19, 2023 Category: Science Source Type: news

Bless you! Meet the flu hunters trying to stop the next pandemic in its tracks
Remember flu? Despite lockdowns holding it at bay, a small group of scientists is searching the globe for deadly new strains – and to work out what to put in next winter’s vaccinesLast month, a small group of international scientists met to decide an issue critical to the health of millions of people all over the planet. For once, it wasn ’t about coronavirus, although these experts know a lot about that, too. The task in hand was to save us from a bug we’ve been fighting since before the days of Hippocrates, the first doctor to describe it in 400BC. It’s an adversary potentially as much of a threat as Covid. The...
Source: Guardian Unlimited Science - March 19, 2022 Category: Science Authors: Sarah Boseley. Portraits: David Levene Tags: Flu Vaccines and immunisation Bird flu Health Society Flu pandemic & wellbeing World Health Organization Coronavirus Infectious diseases Life and style Medical research Science World news Microbiology Source Type: news

Poor support for self-isolation undermines the UK's Covid vaccination effort
The more the virus is allowed to replicate in the community, the greater the risk of mutations that escape the vaccinesThe UK currently has no plan to eliminate coronavirus from our shores. Lockdown will minimise contacts and protect the NHS. Rapid distribution of vaccines will protect the vulnerable, until all adults receive the vaccine in the longer term. Then we can treat the virus like seasonal flu, with booster doses to protect against new variants. At Monday ’spress briefing, the deputy chief medical officer for England, Jonathan Van-Tam, confirmed as much.So the national strategy has not changed. In early February...
Source: Guardian Unlimited Science - February 10, 2021 Category: Science Authors: Anthony Costello Tags: Coronavirus Vaccines and immunisation Patrick Vallance Health Infectious diseases Politics Science Society UK news World news Source Type: news

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
             Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dose, post-exposure preventive treatment for influenza,” said Le...
Source: Roche Media News - November 24, 2020 Category: Pharmaceuticals Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Research Provides No Basis for Pandemic Travel Bans
CONCLUSIONThe pre ‐​COVID‐​19 research is unanimous that governments cannot expect to rely on travel restrictions to prevent the spread of pandemics similar to influenza. Travel restrictions do not prevent the spread of disease and may only delay it for a few days or weeks if implemented prior to the interna tional transmission of the disease. The Trump administration’s travel restrictions waited until after the virus had already entered the United States, and they exempted many travelers from China, not to mention the rest of the world.[30]The research shows that the Trump administration should have known that ...
Source: Cato-at-liberty - April 15, 2020 Category: American Health Authors: David J. Bier Source Type: blogs

Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Authors: Di Pierro F, Bertuccioli A, Cavecchia I Abstract The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans ...
Source: Minerva Gastroenterologica e Dietologica - March 14, 2020 Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research

Global Solidarity, Collaboration and Urgent Action Needed to Defeat the New Coronavirus Outbreak
Once in a very rare while, a single, serious challenge consumes the attention of the entire world. We are living through one such period today as countries and communities come together to end the new coronavirus outbreak. This virus, provisionally known as the “2019-novel coronavirus,” has, as of 3 February 2020, spread to 24 countries, with over 17,000 people being infected to date, 99% of them in China. The limited numbers of cases elsewhere around the world – just 153 so far – show that efforts to contain the virus in China are curbing its global spread, alongside the detection and clinical care...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Dr Tedros Adhanom Ghebreyesus Tags: Uncategorized health ideas Source Type: news